Applicant, as named in the Orange Book

La Jolla Pharma

Next listed expiry: Giapreza on 6 Jan 2037. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Giapreza · 2 strengths angiotensin ii acetate	angiotensin ii acetate	209360	6 Jan 2037	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.